138 related articles for article (PubMed ID: 8612353)
1. IL-15 induces the release of soluble IL-2Ralpha from human peripheral blood mononuclear cells.
Treiber-Held S; Stewart DM; Kurman CC; Nelson DL
Clin Immunol Immunopathol; 1996 Apr; 79(1):71-8. PubMed ID: 8612353
[TBL] [Abstract][Full Text] [Related]
2. Release of sIL-2R alpha from and activation of native human peripheral blood mononuclear cells by recombinant IL-15.
Treiber-Held S; Stewart DM; Barraclough HA; Kurman CC; Nelson DL
Clin Immunol Immunopathol; 1996 Jul; 80(1):67-75. PubMed ID: 8674241
[TBL] [Abstract][Full Text] [Related]
3. Increased serum-soluble interleukin-2 receptor in burn patients: characterization and effects on the immune system.
Jobin N; Garrel D; Bernier J
Hum Immunol; 2000 Mar; 61(3):233-46. PubMed ID: 10689113
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the effect of GHRH(1-44)NH2 on the secretion of interleukin-2 (IL-2) and soluble IL-2 receptor alpha (sIL-2Ralpha) from human peripheral blood mononuclear cells in vitro].
Siejka A; Stepień T; Ławnicka H; Krupiński R; Komorowski J; Stepień H
Endokrynol Pol; 2005; 56(5):773-8. PubMed ID: 16817143
[TBL] [Abstract][Full Text] [Related]
5. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
Elg SA; Hill RB; Heldman L; Ramakrishnan S
Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
[TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.
El Houda Agueznay N; Badoual C; Hans S; Gey A; Vingert B; Peyrard S; Quintin-Colonna F; Ravel P; Bruneval P; Roncelin S; Lelongt B; Bertoglio J; Fridman WH; Brasnu D; Tartour E
Clin Exp Immunol; 2007 Oct; 150(1):114-23. PubMed ID: 17680822
[TBL] [Abstract][Full Text] [Related]
7. Effects of hCG and beta-hCG on IL-2 and sIL-2R secretion from human peripheral blood mononuclear cells: a dose-response study in vitro.
Komorowski J; Gradowski G; Stepień H
Immunol Lett; 1997 Oct; 59(1):29-33. PubMed ID: 9334854
[TBL] [Abstract][Full Text] [Related]
8. Distinctions in lymphocyte responses to IL-2 and IL-15 reflect differential ligand binding interactions with the IL-2Rbeta chain and suggest differential roles for the IL-2Ralpha and IL-15Ralpha subunits.
de Jong JL; Farner NL; Sondel PM
Cytokine; 1998 Dec; 10(12):920-30. PubMed ID: 10049515
[TBL] [Abstract][Full Text] [Related]
9. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
10. Effect of luteinizing hormone alpha-subunit on IL-2 and sIL-2R in vitro secretions from human peripheral blood mononuclear cells.
Komorowski J; Gradowski G; Stepień H
Cytobios; 1997; 89(356):31-7. PubMed ID: 9297814
[TBL] [Abstract][Full Text] [Related]
11. Effect of verapamil on the IL-2 binding to its active receptor and on the release of IL-2 receptor by activated PBMC.
Mikhail N; Raska K; Raskova J; Degiannis D
Immunopharmacology; 1993; 25(1):29-36. PubMed ID: 8320080
[TBL] [Abstract][Full Text] [Related]
12. IL-2 regulation of soluble IL-2 receptor levels following thermal injury.
Teodorczyk-Injeyan JA; Sparkes BG; Lalani S; Peters WJ; Mills GB
Clin Exp Immunol; 1992 Oct; 90(1):36-42. PubMed ID: 1382903
[TBL] [Abstract][Full Text] [Related]
13. IL-2 induces conformational changes in its preassembled receptor core, which then migrates in lipid raft and binds to the cytoskeleton meshwork.
Pillet AH; Lavergne V; Pasquier V; Gesbert F; Thèze J; Rose T
J Mol Biol; 2010 Nov; 403(5):671-92. PubMed ID: 20816854
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Li WY; Liu CC; Wu YC; Huang MH
Clin Cancer Res; 2000 Apr; 6(4):1445-51. PubMed ID: 10778976
[TBL] [Abstract][Full Text] [Related]
15. Surface and intracellular interleukin-2 receptor expression on various resting and activated populations involved in cell-mediated immunity in human peripheral blood.
Hodge S; Hodge G; Flower R; Han P
Scand J Immunol; 2000 Jan; 51(1):67-72. PubMed ID: 10632978
[TBL] [Abstract][Full Text] [Related]
16. Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2.
Kobayashi H; Tagaya Y; Han ES; Kim IS; Le N; Paik CH; Pastan I; Nelson DL; Waldmann TA; Carrasquillo JA
Cytokine; 1999 Dec; 11(12):1065-75. PubMed ID: 10623432
[TBL] [Abstract][Full Text] [Related]
17. Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies.
Mantovani G; Macciò A; Astara G; Contini L; Esu S; Littera S; Arangino V; Lai P; Proto E; Pusceddu G
Cell Biophys; 1993; 22(1-3):79-99. PubMed ID: 7889544
[TBL] [Abstract][Full Text] [Related]
18. Effects of thyrotropin, follicle stimulating hormone and luteinizing hormone on sIL-2R in vitro secretion from human peripheral blood mononuclear cells.
Komorowski J; Jankiewicz J; Stepień H
Cytobios; 1998; 93(372):43-8. PubMed ID: 9721635
[TBL] [Abstract][Full Text] [Related]
19. Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma.
Yang ZZ; Grote DM; Ziesmer SC; Manske MK; Witzig TE; Novak AJ; Ansell SM
Blood; 2011 Sep; 118(10):2809-20. PubMed ID: 21719603
[TBL] [Abstract][Full Text] [Related]
20. Soluble cytokine receptors (sIL-2Rα, sIL-2Rβ) induce subunit-specific behavioral responses and accumulate in the cerebral cortex and basal forebrain.
Zalcman SS; Patel A; Mohla R; Zhu Y; Siegel A
PLoS One; 2012; 7(4):e36316. PubMed ID: 22558434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
